欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
CZ/H/0255/001
药品名称
OSAGRAND 3 MG/3 ML
活性成分
ibandronic acid 3.0 mg
剂型
Solution for injection
上市许可持有人
(ZNP) ZENTIVA, k.s., Praha
参考成员国 - 产品名称
Czechia (CZ)
sukls148071/2015
互认成员国 - 产品名称
Poland (PL)
Osagrand
Latvia (LV)
Osagrand 3 mg/3 ml šķīdums injekcijām
Lithuania (LT)
Osagrand 3 mg injekcinis tirpalas
Romania (RO)
Osagrand 3 mg/3ml solutie injectabila
许可日期
2011/05/29
最近更新日期
2023/08/01
药物ATC编码
M05BA06 ibandronic acid
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
Ibandronate inj CZ_H_0255_001 PSUSA 2022_08 cl
Date of last change:2022/12/01
Final SPC
|
CZ-H-255 Ibandronic acid inj. PI
Date of last change:2011/12/08
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase